These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Accumulation of diacylgylcerol in platelet phosphoinositide turnover in schizophrenia: a biological marker of good prognosis? Kaiya H; Nishida A; Imai A; Nakashima S; Nozawa Y Biol Psychiatry; 1989 Nov; 26(7):669-76. PubMed ID: 2553139 [TBL] [Abstract][Full Text] [Related]
3. What can the investigation of phosphoinositide signaling system in platelets of schizophrenic patients tell us? Strunecká A; Rípová D Prostaglandins Leukot Essent Fatty Acids; 1999 Jul; 61(1):1-5. PubMed ID: 10477034 [TBL] [Abstract][Full Text] [Related]
4. Incorporation of synthetic 1,2-diacylglycerol into platelet phosphatidylinositol is increased by cyclic AMP. Lapetina EG FEBS Lett; 1986 Jan; 195(1-2):111-4. PubMed ID: 3002850 [TBL] [Abstract][Full Text] [Related]
6. Biological mechanisms of schizophrenia: an update. Neylan TC; van Kammen DP Psychiatr Med; 1990; 8(1):41-52. PubMed ID: 1974079 [No Abstract] [Full Text] [Related]
7. Identify the specific role of regional changes for the complex symptoms of schizophrenia. Tretter F; Müller WE; Carlsson A Pharmacopsychiatry; 2006 Feb; 39 Suppl 1():S1-2. PubMed ID: 16508887 [No Abstract] [Full Text] [Related]
8. Interaction of antidepressant drugs with phosphoinositide turnover in human platelets and rat brain. Pandey GN; Pandey SC; Davis JM Clin Neuropharmacol; 1992; 15 Suppl 1 Pt A():202A-203A. PubMed ID: 1354025 [No Abstract] [Full Text] [Related]
9. Recent concepts in clinical psychiatry: drug treatment in schizophrenia. Hussain SH J Pak Med Assoc; 1991 Sep; 41(9):229-34. PubMed ID: 1683911 [No Abstract] [Full Text] [Related]
10. [Current status of biochemical hypotheses in the pathogenesis of schizophrenia]. Kornhuber J; Weller M Nervenarzt; 1994 Nov; 65(11):741-54. PubMed ID: 7816150 [TBL] [Abstract][Full Text] [Related]
11. Psychobiology of schizophrenia: a neo-Jacksonian detour. Sulkowski A Perspect Biol Med; 1983; 26(2):205-18. PubMed ID: 6133263 [No Abstract] [Full Text] [Related]
12. Lipid peroxidation, phosphoinositide turnover and protein kinase C activation in human platelets treated with anthracyclines and their complexes with Fe(III). Banfi P; Parolini O; Lanzi C; Gambetta RA Biochem Pharmacol; 1992 Apr; 43(7):1521-7. PubMed ID: 1314604 [TBL] [Abstract][Full Text] [Related]
13. [Schizophrenia and neural transmission: an excess of analogical treatment?]. Tassin JP Encephale; 1996 Oct; 22 Spec No 3():91-8. PubMed ID: 9036015 [No Abstract] [Full Text] [Related]
15. Regulation and role of phosphoinositide phosphorylation in human platelets. Thomas LM; Holub BJ Prog Lipid Res; 1992; 31(4):399-416. PubMed ID: 1338960 [No Abstract] [Full Text] [Related]
16. New perspectives on the clinical neurobiology of treatment response in schizophrenia. Honer WG Can J Psychiatry; 1994 Feb; 39(1):34-42. PubMed ID: 7910778 [TBL] [Abstract][Full Text] [Related]
17. Strontium ions stimulate phosphoinositide metabolism in human blood platelets. Best LC; Bone EA; Russell RG FEBS Lett; 1981 Nov; 134(1):88-90. PubMed ID: 9222331 [No Abstract] [Full Text] [Related]
18. The neuroanatomies of schizophrenia. Buchanan RW; Carpenter WT Schizophr Bull; 1997; 23(3):367-72. PubMed ID: 9327503 [TBL] [Abstract][Full Text] [Related]
19. Towards systemic theories in biological psychiatry. Bender W; Albus M; Möller HJ; Tretter F Pharmacopsychiatry; 2006 Feb; 39 Suppl 1():S4-9. PubMed ID: 16508889 [TBL] [Abstract][Full Text] [Related]
20. Clinical correlates of platelet prostaglandin receptor subsensitivity in schizophrenia. Kanof PD; Davidson M; Johns CA; Mohs RC; Davis KL Am J Psychiatry; 1987 Dec; 144(12):1556-60. PubMed ID: 2825548 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]